BioSpace News Archive

Aetna®, a CVS Health® company, announced it will ship boxes of specially curated, over-the-counter items to all its Medicare Advantage members across the country.

UV Angel, a leader in pathogen control technology, today announced the manufacturing ramp up of its UV Angel Clean Air™ product line that neutralizes airborne pathogens

Sept. 15, 2020 17:45 UTC Company has 89 pipeline projects spread across 6 targeted therapeutic areas with 4 programs in registration and 23 in Phase 3 27 key programs highlighted, including assets that could potentially contribute revenue by 2025 and others in the 2026-2028 time frame Pipeline contributes to the Company’s expectation of at least 6% revenue CAGR over the next five years – and delivery of longer-term topline growth beyond that period Maj

Retia Medical is pleased to announce the successful installation of its Argos Cardiac Output monitor at The Johns Hopkins Hospital.

Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, announced that it has spun out and completed the initial financing of $55M for a newly formed healthcare company, PrognomIQ, Inc.

National Association of Specialty Pharmacy (NASP) was pleased to announce the winners of specialty pharmacy’s highly anticipated Annual Meeting Awards and welcomed new board members at the eighth annual NASP 2020 Annual Meeting & Expo Virtual Experience on September 15, 2020 .

Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) announced today the record date and expected subscription period for its previously-announced rights offering to raise proceeds of approximately $43 million. The proceeds from the rights offering will be utilized to position the Company as a public company acquisition vehicle, where it can become an acquisition platform and more fully utilize its net operating loss tax carryfor

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services under the U.S. Department of Health and Human

ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the non-medical health and wellness market in China, today announced its unaudited financial results for the second quarter ended June 30, 2020.

Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation of 7,000,000 shares of the Company’s common stock